FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
InVision Precision Cardiac Amyloid
K Number: K243866
·
Decision May 21, 2025
Classifications
1
FEI Numbers
3
Registration Numbers
3
Same Product Code
2
Applicant Total
2
Review Days
155
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- InVision Precision Cardiac Amyloid
- K Number
- K243866
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 870.2200
- Medical Specialty
- Cardiovascular
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- InVision Medical Technology Corporation
- Date Received
- December 17, 2024
- Decision Date
- May 21, 2025
- Product Code
- SDJ
- Advisory Committee
- Cardiovascular
- Review Advisory Committee
- CV
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| SDJ | Adjunctive Cardiac Amyloidosis Status Indicator | FDA class 2 | Cardiovascular |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (SDJ), ordered by most recent decision date.
Us2.ca
FDA 510(k)
FDA Class 2
·Cardiovascular
EchoGo Amyloidosis (1.0)
FDA 510(k)
FDA Class 2
·Cardiovascular
Other Clearances by InVision Medical Technology Corporation
| K Number | Device Name | ||
|---|---|---|---|
| K232331 | InVision Precision LVEF (LVEF) | Apr 25, 2024 | Substantially Equivalent |